Current Situation
October 14, 2012 10:30 AM EDT
CDC Responds to Multistate Fungal Meningitis Outbreak
FDA Updates
- CDC's guidance to patients has not changed as a result of the expanded voluntary recall of all New England Compounding Center (NECC) products, announced October 6. Patients who feel ill and are concerned about whether they received a medication from one of the NECC products recalled on September 26 should contact their physician.
- The type of meningitis that has been found in the investigation is caused by fungi (Exserohilum and Aspergillus) that are common in the environment but rarely cause meningitis. This form of fungal meningitis is not contagious.
- Clinicians should contact patients who have received medicines associated with three lots of preservative-free methylprednisolone acetate (80mg/ml) from the NECC that were recalled on September 26, 2012. The potentially contaminated injections were given starting May 21, 2012. See updated Clinician Guidance for more information, including new case definitions.
- Patients and clinicians need to remain vigilant for onset of symptoms because fungal infections can be slow to develop. In this outbreak symptoms typically have appeared 1 to 4 weeks following injection, but it’s important to know that longer and shorter periods of time between injection and onset of symptoms have been reported. Therefore, patients and physicians need to closely watch for symptoms for at least several months following the injection. See updated Patient Guidance for more information, and contact your physician if you are concerned you may have become ill from your injection.
No hay comentarios:
Publicar un comentario